ADMA BIOLOGICS, INC. Operating Expenses
ADMA BIOLOGICS, INC. (ADMA) reported Operating Expenses of $33.83 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-05
- ADMA BIOLOGICS, INC. operating expenses for the quarter ending 2026-06-30 was $33.83M, a 38.49% increase year-over-year.
- ADMA BIOLOGICS, INC. operating expenses for the quarter ending 2026-03-31 was $22.48M, a 14.27% decline year-over-year.
- ADMA BIOLOGICS, INC. operating expenses for the quarter ending 2025-12-31 was $26.07M, a 4.22% increase year-over-year.
- ADMA BIOLOGICS, INC. operating expenses for the quarter ending 2025-09-30 was $24.61M, a 22.94% increase year-over-year.
- ADMA BIOLOGICS, INC. operating expenses for fiscal 2025 was $101.32M, a 25.76% increase from fiscal 2024.
- ADMA BIOLOGICS, INC. operating expenses for fiscal 2024 was $80.57M, a 19.70% increase from fiscal 2023.
- ADMA BIOLOGICS, INC. operating expenses for fiscal 2023 was $67.31M, a 9.81% decline from fiscal 2022.
- ADMA BIOLOGICS, INC. operating expenses for fiscal 2022 was $74.63M, a 25.33% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 64 month | Operating Expenses 67 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $33.83M 10-Q · filed 2026-08-05 | $56.31M 10-Q · filed 2026-08-05 | $82.37M derived: sum of 3 quarters · filed 2026-08-05 | $106.99M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2026-03-31 | $22.48M 10-Q · filed 2026-05-06 | $48.54M derived: sum of 2 quarters · filed 2026-05-06 | $73.16M derived: sum of 3 quarters · filed 2026-05-06 | $97.58M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-12-31 | $26.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $50.68M derived: sum of 2 quarters · filed 2026-02-25 | $75.11M derived: sum of 3 quarters · filed 2026-08-05 | $101.32M 10-K · filed 2026-02-25 | ||||||
| 2025-09-30 | $24.61M 10-Q · filed 2025-11-05 | $49.04M derived: sum of 2 quarters · filed 2026-08-05 | $75.26M 10-Q · filed 2025-11-05 | $100.27M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-06-30 | $24.43M 10-Q · filed 2026-08-05 | $50.65M 10-Q · filed 2026-08-05 | $75.66M derived: sum of 3 quarters · filed 2026-08-05 | $95.68M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-03-31 | $26.22M 10-Q · filed 2026-05-06 | $51.23M derived: sum of 2 quarters · filed 2026-05-06 | $71.25M derived: sum of 3 quarters · filed 2026-05-06 | $89.50M derived: sum of 4 quarters · filed 2026-05-06 | ||||||
| 2024-12-31 | $25.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $45.03M derived: sum of 2 quarters · filed 2026-02-25 | $63.28M derived: sum of 3 quarters · filed 2026-02-25 | $80.57M 10-K · filed 2026-02-25 | ||||||
| 2024-09-30 | $20.02M 10-Q · filed 2025-11-05 | $38.27M derived: sum of 2 quarters · filed 2025-11-05 | $55.56M 10-Q · filed 2025-11-05 | $72.41M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2024-06-30 | $18.25M 10-Q · filed 2025-08-06 | $35.54M 10-Q · filed 2025-08-06 | $52.39M derived: sum of 3 quarters · filed 2026-02-25 | $68.36M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2024-03-31 | $17.29M 10-Q · filed 2025-05-07 | $34.14M derived: sum of 2 quarters · filed 2026-02-25 | $50.11M derived: sum of 3 quarters · filed 2026-02-25 | $67.27M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2023-12-31 | $16.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $32.82M derived: sum of 2 quarters · filed 2026-02-25 | $49.98M derived: sum of 3 quarters · filed 2026-02-25 | $67.31M 10-K · filed 2026-02-25 | ||||||
| 2023-09-30 | $15.97M 10-Q · filed 2024-11-07 | $15.97M 10-Q · filed 2023-11-08 | $33.13M derived: sum of 2 quarters · filed 2024-11-07 | $50.46M 10-Q · filed 2024-11-07 | $50.46M 10-Q · filed 2023-11-08 | $70.69M derived: sum of 4 quarters · filed 2025-03-18 | ||||
| 2023-06-30 | $17.16M 10-Q · filed 2024-08-08 | $17.16M 10-Q · filed 2023-08-09 | $34.49M 10-Q · filed 2024-08-08 | $34.49M 10-Q · filed 2023-08-09 | $54.72M derived: sum of 3 quarters · filed 2025-03-18 | $73.70M derived: sum of 4 quarters · filed 2025-03-18 | ||||
| 2023-03-31 | $17.33M 10-Q · filed 2024-05-09 | $17.33M 10-Q · filed 2023-05-10 | $37.56M derived: sum of 2 quarters · filed 2025-03-18 | $56.53M derived: sum of 3 quarters · filed 2025-03-18 | $73.48M derived: sum of 4 quarters · filed 2025-03-18 | |||||
| 2022-12-31 | $20.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $39.21M derived: sum of 2 quarters · filed 2025-03-18 | $56.15M derived: sum of 3 quarters · filed 2025-03-18 | $74.63M 10-K · filed 2025-03-18 | $74.63M 10-K · filed 2023-03-23 | |||||
| 2022-09-30 | $18.97M 10-Q · filed 2023-11-08 | $35.92M derived: sum of 2 quarters · filed 2023-11-08 | $54.39M 10-Q · filed 2023-11-08 | $71.10M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2022-06-30 | $16.94M 10-Q · filed 2023-08-09 | $35.42M 10-Q · filed 2023-08-09 | $52.12M derived: sum of 3 quarters · filed 2024-02-28 | $66.95M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2022-03-31 | $18.48M 10-Q · filed 2023-05-10 | $35.18M derived: sum of 2 quarters · filed 2024-02-28 | $50.00M derived: sum of 3 quarters · filed 2024-02-28 | $64.58M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2021-12-31 | $16.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $31.53M derived: sum of 2 quarters · filed 2024-02-28 | $46.10M derived: sum of 3 quarters · filed 2024-02-28 | $59.55M 10-K · filed 2024-02-28 | $59.55M 10-K · filed 2022-03-24 | |||||
| 2021-09-30 | $14.82M 10-Q · filed 2022-11-09 | $35.12M 10-Q · filed 2021-11-10 | $29.40M derived: sum of 2 quarters · filed 2022-11-09 | $42.84M 10-Q · filed 2022-11-09 | $99.74M 10-Q · filed 2021-11-10 | $12.73M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $14.58M 10-Q · filed 2022-08-10 | $33.41M 10-Q · filed 2021-08-11 | $28.02M 10-Q · filed 2022-08-10 | $64.62M 10-Q · filed 2021-08-11 | -$2.09M derived: sum of 3 quarters · filed 2022-08-10 | $21.98M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $13.44M 10-Q · filed 2022-05-11 | $31.21M 10-Q · filed 2021-05-12 | -$16.67M derived: sum of 2 quarters · filed 2022-05-11 | $7.41M derived: sum of 3 quarters · filed 2022-05-11 | $32.32M derived: sum of 4 quarters · filed 2022-05-11 | |||||
| 2020-12-31 | -$30.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$6.04M derived: sum of 2 quarters · filed 2022-03-24 | $18.87M derived: sum of 3 quarters · filed 2022-03-24 | $45.84M 10-K · filed 2022-03-24 | $107.13M 10-K · filed 2021-03-25 | |||||
| 2020-09-30 | $24.08M 10-Q · filed 2021-11-10 | $48.99M derived: sum of 2 quarters · filed 2021-11-10 | $75.96M 10-Q · filed 2021-11-10 | $95.82M derived: sum of 4 quarters · filed 2021-11-10 | ||||||
| 2020-06-30 | $24.91M 10-Q · filed 2021-08-11 | $51.88M 10-Q · filed 2021-08-11 | $71.74M derived: sum of 3 quarters · filed 2021-08-11 | $88.02M derived: sum of 4 quarters · filed 2021-08-11 | ||||||
| 2020-03-31 | $26.97M 10-Q · filed 2021-05-12 | $46.83M derived: sum of 2 quarters · filed 2021-05-12 | $63.11M derived: sum of 3 quarters · filed 2021-05-12 | $81.01M derived: sum of 4 quarters · filed 2021-05-12 | ||||||
| 2019-12-31 | $19.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $36.14M derived: sum of 2 quarters · filed 2021-03-25 | $54.04M derived: sum of 3 quarters · filed 2021-03-25 | $70.77M 10-K · filed 2021-03-25 | ||||||
| 2019-09-30 | $16.27M 10-Q · filed 2020-11-05 | $34.17M derived: sum of 2 quarters · filed 2020-11-05 | $50.91M 10-Q · filed 2020-11-05 | $71.51M derived: sum of 4 quarters · filed 2020-11-05 | ||||||
| 2019-06-30 | $17.90M 10-Q · filed 2020-08-05 | $34.64M 10-Q · filed 2020-08-05 | $55.24M derived: sum of 3 quarters · filed 2020-08-05 | $73.26M derived: sum of 4 quarters · filed 2020-08-05 | ||||||
| 2019-03-31 | $16.74M 10-Q · filed 2020-05-06 | $37.34M derived: sum of 2 quarters · filed 2020-05-06 | $55.36M derived: sum of 3 quarters · filed 2020-05-06 | $73.44M derived: sum of 4 quarters · filed 2020-05-06 | ||||||
| 2018-12-31 | $20.60M 10-K · filed 2019-03-13 | $38.63M derived: sum of 2 quarters · filed 2019-11-06 | $56.70M derived: sum of 3 quarters · filed 2019-11-06 | $77.27M 10-K · filed 2020-03-13 | ||||||
| 2018-09-30 | $18.02M 10-Q · filed 2019-11-06 | $36.10M derived: sum of 2 quarters · filed 2019-11-06 | $56.67M 10-Q · filed 2019-11-06 | $79.22M derived: sum of 4 quarters · filed 2019-11-06 | ||||||
| 2018-06-30 | $18.07M 10-Q · filed 2019-08-08 | $38.65M 10-Q · filed 2019-08-08 | $61.19M derived: sum of 3 quarters · filed 2019-08-08 | $80.35M derived: sum of 4 quarters · filed 2019-08-08 | ||||||
| 2018-03-31 | $20.57M 10-Q · filed 2019-05-08 | $43.12M derived: sum of 2 quarters · filed 2019-05-08 | $62.28M derived: sum of 3 quarters · filed 2019-05-08 | $74.08M derived: sum of 4 quarters · filed 2019-05-08 | ||||||
| 2017-12-31 | $22.55M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $41.70M derived: sum of 2 quarters · filed 2019-03-13 | $53.50M derived: sum of 3 quarters · filed 2019-03-13 | $62.07M 10-K · filed 2019-03-13 | ||||||
| 2017-09-30 | $19.16M 10-Q · filed 2018-11-09 | $30.96M derived: sum of 2 quarters · filed 2018-11-09 | $39.52M 10-Q · filed 2018-11-09 | $46.80M derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2017-06-30 | $11.80M 10-Q · filed 2018-08-10 | $20.37M 10-Q · filed 2018-08-10 | $27.64M derived: sum of 3 quarters · filed 2018-08-10 | $34.31M derived: sum of 4 quarters · filed 2018-08-10 | ||||||
| 2017-03-31 | $8.57M 10-Q · filed 2018-05-14 | $15.84M derived: sum of 2 quarters · filed 2018-05-14 | $22.51M derived: sum of 3 quarters · filed 2018-05-14 | $30.27M derived: sum of 4 quarters · filed 2018-05-14 | ||||||
| 2016-12-31 | $7.27M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $13.95M derived: sum of 2 quarters · filed 2018-03-29 | $21.71M derived: sum of 3 quarters · filed 2018-03-29 | $27.99M 10-K · filed 2018-03-29 | ||||||
| 2016-09-30 | $6.67M 10-Q · filed 2017-11-03 | $14.44M derived: sum of 2 quarters · filed 2017-11-03 | $20.72M 10-Q · filed 2017-11-03 | $27.36M derived: sum of 4 quarters · filed 2017-11-03 | ||||||
| 2016-06-30 | $7.76M 10-Q · filed 2017-08-11 | $14.05M 10-Q · filed 2017-08-11 | $20.69M derived: sum of 3 quarters · filed 2017-08-11 | $27.20M derived: sum of 4 quarters · filed 2017-08-11 | ||||||
| 2016-03-31 | $6.28M 10-Q · filed 2017-05-12 | $12.93M derived: sum of 2 quarters · filed 2017-05-12 | $19.44M derived: sum of 3 quarters · filed 2017-05-12 | $24.27M derived: sum of 4 quarters · filed 2017-05-12 | ||||||
| 2015-12-31 | $6.64M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $13.16M derived: sum of 2 quarters · filed 2017-02-24 | $17.99M derived: sum of 3 quarters · filed 2017-02-24 | $22.69M 10-K · filed 2017-02-24 | ||||||
| 2015-09-30 | $6.52M 10-Q · filed 2016-11-10 | $11.34M derived: sum of 2 quarters · filed 2016-11-10 | $16.05M 10-Q · filed 2016-11-10 | $21.25M derived: sum of 4 quarters · filed 2016-11-10 | ||||||
| 2015-06-30 | $4.83M 10-Q · filed 2016-08-12 | $9.53M 10-Q · filed 2016-08-12 | $14.73M derived: sum of 3 quarters · filed 2016-08-12 | $19.13M derived: sum of 4 quarters · filed 2016-08-12 | ||||||
| 2015-03-31 | $4.71M 10-Q · filed 2016-05-13 | $9.90M derived: sum of 2 quarters · filed 2016-05-13 | $14.31M derived: sum of 3 quarters · filed 2016-05-13 | $19.39M derived: sum of 4 quarters · filed 2016-05-13 | ||||||
| 2014-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $9.60M derived: sum of 2 quarters · filed 2016-03-23 | $14.69M derived: sum of 3 quarters · filed 2016-03-23 | $21.93M 10-K · filed 2016-03-23 | ||||||
| 2014-09-30 | $4.40M 10-Q · filed 2015-11-10 | $9.49M derived: sum of 2 quarters · filed 2015-11-10 | $16.74M 10-Q · filed 2015-11-10 | $21.68M derived: sum of 4 quarters · filed 2015-11-10 | ||||||
| 2014-06-30 | $5.09M 10-Q · filed 2015-08-11 | $12.33M 10-Q · filed 2015-08-11 | $17.27M derived: sum of 3 quarters · filed 2015-08-11 | $20.91M derived: sum of 4 quarters · filed 2015-08-11 | ||||||
| 2014-03-31 | $7.24M 10-Q · filed 2015-05-12 | $12.19M derived: sum of 2 quarters · filed 2015-05-12 | $15.83M derived: sum of 3 quarters · filed 2015-05-12 | $21.41M derived: sum of 4 quarters · filed 2015-05-12 | ||||||
| 2013-12-31 | $4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $8.58M derived: sum of 2 quarters · filed 2015-03-09 | $14.17M derived: sum of 3 quarters · filed 2015-03-09 | $18.11M 10-K · filed 2015-03-09 | ||||||
| 2013-09-30 | $3.64M 10-Q · filed 2014-11-10 | $9.22M derived: sum of 2 quarters · filed 2014-11-10 | $13.17M 10-Q · filed 2014-11-10 | $15.93M derived: sum of 4 quarters · filed 2014-11-10 | ||||||
| 2013-06-30 | $5.59M 10-Q · filed 2014-08-11 | $9.53M 10-Q · filed 2014-08-11 | $12.29M derived: sum of 3 quarters · filed 2014-08-11 | $15.90M derived: sum of 4 quarters · filed 2014-08-11 | ||||||
| 2013-03-31 | $3.94M 10-Q · filed 2014-05-12 | $3.41M 10-Q · filed 2013-05-14 | $6.71M derived: sum of 2 quarters · filed 2014-05-12 | $10.32M derived: sum of 3 quarters · filed 2014-05-12 | $11.75M derived: sum of 4 quarters · filed 2014-05-12 | |||||
| 2012-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $6.37M derived: sum of 2 quarters · filed 2014-03-28 | $7.81M derived: sum of 3 quarters · filed 2014-03-28 | $9.03M 10-K · filed 2014-03-28 | $8.36M 10-K · filed 2013-03-06 | |||||
| 2012-09-30 | $3.61M 10-Q · filed 2013-11-12 | $3.46M 10-Q · filed 2012-11-13 | $5.05M derived: sum of 2 quarters · filed 2013-11-12 | $6.26M 10-Q · filed 2013-11-12 | $5.97M 10-Q · filed 2012-11-13 | $6.27M derived: sum of 4 quarters · filed 2013-11-12 | ||||
| 2012-06-30 | $1.44M 10-Q · filed 2013-08-12 | $1.29M 10-Q · filed 2012-08-14 | $2.65M 10-Q · filed 2013-08-12 | $2.51M 10-Q · filed 2012-08-14 | $2.66M derived: sum of 3 quarters · filed 2013-08-12 | $3.43M derived: sum of 4 quarters · filed 2013-08-12 | ||||
| 2012-03-31 | $1.22M 10-Q · filed 2013-05-14 | $1.22M 10-Q · filed 2012-05-15 | $1.22M derived: sum of 2 quarters · filed 2013-05-14 | $1.99M derived: sum of 3 quarters · filed 2013-05-14 | $4.14M derived: sum of 4 quarters · filed 2013-05-14 | |||||
| 2011-12-31 | $8.33K 10-Q · filed 2012-02-01 | $13.50K 10-Q · filed 2012-02-01 | $2.92M derived: sum of 3 quarters · filed 2012-11-13 | $5.18M 10-K · filed 2013-03-06 | $153.67K 10-Q · filed 2012-02-01 | |||||
| 2011-09-30 | $768.16K 10-Q · filed 2012-11-13 | $5.17K 10-Q · filed 2011-10-28 | $2.92M derived: sum of 2 quarters · filed 2012-11-13 | $4.50M 10-Q · filed 2012-11-13 | $4.51M derived: sum of 4 quarters · filed 2012-11-13 | $145.34K 10-Q · filed 2011-10-28 | ||||
| 2011-06-30 | $2.15M 10-Q · filed 2012-08-14 | $3.73M 10-Q · filed 2012-08-14 | $3.74M derived: sum of 3 quarters · filed 2012-08-14 | $3.74M derived: sum of 4 quarters · filed 2012-08-14 | ||||||
| 2011-03-31 | $1.59M 10-Q · filed 2012-05-15 | $1.59M derived: sum of 2 quarters · filed 2012-05-15 | $1.60M derived: sum of 3 quarters · filed 2012-05-15 | |||||||
| 2010-12-31 | $5.23K 10-Q · filed 2012-02-01 | $9.87K 10-Q · filed 2012-02-01 | ||||||||
| 2010-09-30 | $4.64K 10-Q · filed 2011-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |